https://biotechmorning.com/news/kailera-obesity-pill-side-effects-problem Biotech Morning en 2026-07-28T14:25:58.612Z Kailera's Obesity Pill Works. The Side Effects Might Kill the Deal. https://biotechmorning.com/news/pancreatic-cancer-ras-inhibitor-daraxonrasib-fda Biotech Morning en 2026-07-28T14:25:08.395Z The Cancer That Stumped Drug Makers for 40 Years Just Met Its Match https://biotechmorning.com/news/fda-goes-dark-drug-rejections Biotech Morning en 2026-07-28T14:24:15.628Z The FDA Just Went Dark on Drug Rejections https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition Biotech Morning en 2026-07-28T14:23:27.165Z Vertex Just Bet $10 Billion on Your Hormones https://biotechmorning.com/news/zymeworks-acquires-theravance-929m-royalty-bet Biotech Morning en 2026-07-28T14:22:33.571Z The $929M Bet on a Drug That Already Failed Twice https://biotechmorning.com/news/awiqli-once-weekly-insulin-india-launch Biotech Morning en 2026-07-28T14:21:33.359Z One Shot a Week: The Insulin That Could Change Everything for 100 Million Indians https://biotechmorning.com/news/moderna-bird-flu-vaccine-phase-3-trial-2 Biotech Morning en 2026-07-28T14:20:31.950Z Moderna's Betting on Bird Flu Before It Bets on Us https://biotechmorning.com/news/roche-walks-away-huntingtons-disease Biotech Morning en 2026-07-28T14:19:38.587Z Roche Just Walked Away From Huntington's Disease. Now What? https://biotechmorning.com/news/glp1-gold-rush-pothole-dr-reddys-semaglutide-delay Biotech Morning en 2026-07-27T14:26:55.531Z The GLP-1 Gold Rush Just Hit a Pothole https://biotechmorning.com/news/prime-medicine-beam-arbitration-gene-editing Biotech Morning en 2026-07-27T14:26:00.355Z Two Gene-Editing Companies Born in the Same Lab Just Went to War https://biotechmorning.com/news/allogene-allo-316-car-t-solid-tumors-breakthrough Biotech Morning en 2026-07-27T14:25:08.546Z The Cancer Therapy That Wasn't Supposed to Work in Solid Tumors https://biotechmorning.com/news/715-million-48-hours-two-bets-reshaping-biotech Biotech Morning en 2026-07-27T14:23:30.923Z $715 Million in 48 Hours: The Two Bets Reshaping Biotech https://biotechmorning.com/news/gsk-alector-neuroscience-collaboration-terminated Biotech Morning en 2026-07-27T14:22:35.305Z GSK Just Lit $700 Million on Fire in the Neuroscience Graveyard https://biotechmorning.com/news/europe-flu-covid-combo-vaccine-moderna Biotech Morning en 2026-07-27T14:21:43.638Z One Shot to Rule Them All: Europe's Bet on a Flu-COVID Combo Vaccine